According to a major new study, a pain medication that millions of Americans rely on for chronic back pain may come with a hidden risk: a significantly higher chance of developing dementia or other cognitive problems.
Compared 26,000 adults
Researchers from Case Western Reserve University and many partner institutions analyzed medical records from 68 health systems across the United States, comparing 26,414 adults prescribed gabapentin for persistent low-back pain with a matched group who had similar pain — but didn’t take the drug.
Their finding was concerning: Adults that received six or more gabapentin prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop mild cognitive impairment (MCI) within 10 years.
The risk was not just limited to older adults. In fact, it was younger American people who saw the most dramatic increases.
Website Disclaimer
The information provided on this website is for general informational and educational purposes only. While we strive to ensure that all content is accurate and up to date, we make no guarantees regarding the completeness, reliability, or accuracy of any information published.
The views and opinions expressed in articles belong to their respective authors and do not necessarily reflect the views of this website. Any action you take based on the information found on this website is strictly at your own risk. We will not be liable for any losses, damages, or inconveniences arising from the use of our content.
Some articles may contain opinions, third-party information, or external links. We do not endorse or guarantee the accuracy of content on external websites and are not responsible for their practices or policies.
All content on this website is provided in good faith and is intended for informational purposes only. Readers are encouraged to verify information independently and seek professional advice where appropriate.
